IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 108 filers reported holding IGM BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,133,788 | +1.7% | 135,783 | +12.4% | 0.00% | – |
| Q2 2023 | $1,114,743 | -31.7% | 120,774 | +1.7% | 0.00% | – |
| Q1 2023 | $1,632,311 | -20.1% | 118,800 | -1.0% | 0.00% | – |
| Q4 2022 | $2,042,017 | -21.0% | 120,048 | +5.6% | 0.00% | -100.0% |
| Q3 2022 | $2,584,000 | +29.6% | 113,649 | +2.8% | 0.00% | – |
| Q2 2022 | $1,994,000 | -11.9% | 110,606 | +30.6% | 0.00% | – |
| Q1 2022 | $2,264,000 | -0.5% | 84,672 | +9.2% | 0.00% | – |
| Q4 2021 | $2,275,000 | -57.0% | 77,544 | -3.7% | 0.00% | -100.0% |
| Q3 2021 | $5,295,000 | -37.8% | 80,514 | -21.3% | 0.00% | 0.0% |
| Q2 2021 | $8,508,000 | +7.6% | 102,254 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $7,909,000 | -22.0% | 103,131 | -10.2% | 0.00% | -50.0% |
| Q4 2020 | $10,142,000 | +14.5% | 114,869 | -4.2% | 0.00% | 0.0% |
| Q3 2020 | $8,854,000 | -10.5% | 119,947 | -11.5% | 0.00% | 0.0% |
| Q2 2020 | $9,895,000 | +96.1% | 135,552 | +50.8% | 0.00% | +100.0% |
| Q1 2020 | $5,046,000 | +82.0% | 89,860 | +23.6% | 0.00% | 0.0% |
| Q4 2019 | $2,773,000 | – | 72,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
| GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
| Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
| Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
| Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
| Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
| Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
| RA Capital Management | 937,500 | $7,828,125 | 0.15% |
| Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |